SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-21-142643
Filing Date
2021-11-22
Accepted
2021-11-22 17:30:33
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 tm2133592-1_s3.htm S-3 500785
2 EXHIBIT 5.1 tm2133592d2_ex5-1.htm EX-5.1 33738
3 EXHIBIT 23.1 tm2133592d2_ex23-1.htm EX-23.1 2374
4 GRAPHIC lg_jaguarhealth-4c.jpg GRAPHIC 68841
5 GRAPHIC tm2133592d2_ex5-1img001.jpg GRAPHIC 6087
  Complete submission text file 0001104659-21-142643.txt   641462
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-261283 | Film No.: 211433780
SIC: 2834 Pharmaceutical Preparations